IMMUNOTHERAPY VERSUS CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS OF SURVIVAL OUTCOMES AND ADVERSE EVENTS. FMHR. 2026;4(5):871-886. Accessed May 26, 2026. https://fmhr.net/index.php/fmhr/article/view/2945